IMIDAZOLE BASED LXR MODULATORS
Methods of using compounds of the invention, such as compounds of Formulae IIa, IIb, IIc, or IId and pharmaceutically acceptable salts thereof are disclosed. The compounds are useful in treating, preventing, inhibiting or ameliorating the symptoms of a disease or disorder that is modulated or otherw...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FLATT, BRENTON T MOHAN, RAJU WANG, TIE-LIN GU, XIAO-HUI MARTIN, RICHARD SCHWEIGER, EDWIN LU, SHAO-PO STEVENS, WILLIAM C., JR XIE, YINONG BUSCH, BRETT B NYMAN, MICHAEL CHARLES |
| description | Methods of using compounds of the invention, such as compounds of Formulae IIa, IIb, IIc, or IId and pharmaceutically acceptable salts thereof are disclosed. The compounds are useful in treating, preventing, inhibiting or ameliorating the symptoms of a disease or disorder that is modulated or otherwise affected by nuclear receptor activity, or in which nuclear receptor activity is implicated. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1910308B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1910308B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1910308B13</originalsourceid><addsrcrecordid>eNrjZJDz9PV0cYzy93FVcHIMdnVR8IkIUvD1dwn1cQzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgGGloYGxgYWTobGRCgBAHXiIPg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMIDAZOLE BASED LXR MODULATORS</title><source>esp@cenet</source><creator>FLATT, BRENTON T ; MOHAN, RAJU ; WANG, TIE-LIN ; GU, XIAO-HUI ; MARTIN, RICHARD ; SCHWEIGER, EDWIN ; LU, SHAO-PO ; STEVENS, WILLIAM C., JR ; XIE, YINONG ; BUSCH, BRETT B ; NYMAN, MICHAEL CHARLES</creator><creatorcontrib>FLATT, BRENTON T ; MOHAN, RAJU ; WANG, TIE-LIN ; GU, XIAO-HUI ; MARTIN, RICHARD ; SCHWEIGER, EDWIN ; LU, SHAO-PO ; STEVENS, WILLIAM C., JR ; XIE, YINONG ; BUSCH, BRETT B ; NYMAN, MICHAEL CHARLES</creatorcontrib><description>Methods of using compounds of the invention, such as compounds of Formulae IIa, IIb, IIc, or IId and pharmaceutically acceptable salts thereof are disclosed. The compounds are useful in treating, preventing, inhibiting or ameliorating the symptoms of a disease or disorder that is modulated or otherwise affected by nuclear receptor activity, or in which nuclear receptor activity is implicated.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140903&DB=EPODOC&CC=EP&NR=1910308B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140903&DB=EPODOC&CC=EP&NR=1910308B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FLATT, BRENTON T</creatorcontrib><creatorcontrib>MOHAN, RAJU</creatorcontrib><creatorcontrib>WANG, TIE-LIN</creatorcontrib><creatorcontrib>GU, XIAO-HUI</creatorcontrib><creatorcontrib>MARTIN, RICHARD</creatorcontrib><creatorcontrib>SCHWEIGER, EDWIN</creatorcontrib><creatorcontrib>LU, SHAO-PO</creatorcontrib><creatorcontrib>STEVENS, WILLIAM C., JR</creatorcontrib><creatorcontrib>XIE, YINONG</creatorcontrib><creatorcontrib>BUSCH, BRETT B</creatorcontrib><creatorcontrib>NYMAN, MICHAEL CHARLES</creatorcontrib><title>IMIDAZOLE BASED LXR MODULATORS</title><description>Methods of using compounds of the invention, such as compounds of Formulae IIa, IIb, IIc, or IId and pharmaceutically acceptable salts thereof are disclosed. The compounds are useful in treating, preventing, inhibiting or ameliorating the symptoms of a disease or disorder that is modulated or otherwise affected by nuclear receptor activity, or in which nuclear receptor activity is implicated.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDz9PV0cYzy93FVcHIMdnVR8IkIUvD1dwn1cQzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgGGloYGxgYWTobGRCgBAHXiIPg</recordid><startdate>20140903</startdate><enddate>20140903</enddate><creator>FLATT, BRENTON T</creator><creator>MOHAN, RAJU</creator><creator>WANG, TIE-LIN</creator><creator>GU, XIAO-HUI</creator><creator>MARTIN, RICHARD</creator><creator>SCHWEIGER, EDWIN</creator><creator>LU, SHAO-PO</creator><creator>STEVENS, WILLIAM C., JR</creator><creator>XIE, YINONG</creator><creator>BUSCH, BRETT B</creator><creator>NYMAN, MICHAEL CHARLES</creator><scope>EVB</scope></search><sort><creationdate>20140903</creationdate><title>IMIDAZOLE BASED LXR MODULATORS</title><author>FLATT, BRENTON T ; MOHAN, RAJU ; WANG, TIE-LIN ; GU, XIAO-HUI ; MARTIN, RICHARD ; SCHWEIGER, EDWIN ; LU, SHAO-PO ; STEVENS, WILLIAM C., JR ; XIE, YINONG ; BUSCH, BRETT B ; NYMAN, MICHAEL CHARLES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1910308B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FLATT, BRENTON T</creatorcontrib><creatorcontrib>MOHAN, RAJU</creatorcontrib><creatorcontrib>WANG, TIE-LIN</creatorcontrib><creatorcontrib>GU, XIAO-HUI</creatorcontrib><creatorcontrib>MARTIN, RICHARD</creatorcontrib><creatorcontrib>SCHWEIGER, EDWIN</creatorcontrib><creatorcontrib>LU, SHAO-PO</creatorcontrib><creatorcontrib>STEVENS, WILLIAM C., JR</creatorcontrib><creatorcontrib>XIE, YINONG</creatorcontrib><creatorcontrib>BUSCH, BRETT B</creatorcontrib><creatorcontrib>NYMAN, MICHAEL CHARLES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FLATT, BRENTON T</au><au>MOHAN, RAJU</au><au>WANG, TIE-LIN</au><au>GU, XIAO-HUI</au><au>MARTIN, RICHARD</au><au>SCHWEIGER, EDWIN</au><au>LU, SHAO-PO</au><au>STEVENS, WILLIAM C., JR</au><au>XIE, YINONG</au><au>BUSCH, BRETT B</au><au>NYMAN, MICHAEL CHARLES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMIDAZOLE BASED LXR MODULATORS</title><date>2014-09-03</date><risdate>2014</risdate><abstract>Methods of using compounds of the invention, such as compounds of Formulae IIa, IIb, IIc, or IId and pharmaceutically acceptable salts thereof are disclosed. The compounds are useful in treating, preventing, inhibiting or ameliorating the symptoms of a disease or disorder that is modulated or otherwise affected by nuclear receptor activity, or in which nuclear receptor activity is implicated.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP1910308B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | IMIDAZOLE BASED LXR MODULATORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A47%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FLATT,%20BRENTON%20T&rft.date=2014-09-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1910308B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |